Don also served as Director, Legal for Cytogen Corporation (NASDAQ: CYTO), a publicly - traded biopharmaceutical company with an established product line in prostate cancer therapeutics and other areas of oncology. (slipakoff.com)
Mr. Hoyt is a technology strategist in the area of oncology, helping to identify clinical opportunities that can be addressed through new technologies and capabilities. (sciencemag.org)
Under his leadership, teams of scientists developed high - throughput assays in the areas of oncology, inflammatory and metabolic diseases, viral transcription, and gene function. (sciencemag.org)